Are OptimizeRx Corporation (NASDAQ:OPRX) Investors Paying Above The Intrinsic Value?
Key Insights The projected fair value for OptimizeRx is US$5.57 based on 2 Stage Free Cash Flow to Equity Current share...
United States For Optimizerx High Quality Alternatives Discounted Cash Flow Uture Cash Flows Free Cash Flow
Source: yahoo.com